Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Operating Leases (2022 - 2025)

LifeStance Health (LFST) has disclosed Operating Leases for 4 consecutive years, with $148.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Leases changed 0.1% to $148.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $148.6 million, a 0.1% change, with the full-year FY2025 number at $148.6 million, changed 0.1% from a year prior.
  • Operating Leases was $148.6 million for Q4 2025 at LifeStance Health, up from $144.2 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $212.6 million in Q4 2022 to a low of $143.4 million in Q2 2025.
  • A 4-year average of $171.6 million and a median of $165.8 million in 2024 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: decreased 19.38% in 2024, then dropped 0.1% in 2025.
  • LifeStance Health's Operating Leases stood at $212.6 million in 2022, then decreased by 14.69% to $181.4 million in 2023, then decreased by 18.01% to $148.7 million in 2024, then fell by 0.1% to $148.6 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Operating Leases are $148.6 million (Q4 2025), $144.2 million (Q3 2025), and $143.4 million (Q2 2025).